This is a preview of subscription content, log in via an institution to check access.
Reference
BioTrends Research Group. The Majority Of Oncologists Will Begin Using Biosimilar Monoclonal Antibodies Within 12 Months Of Launch. Media Release : 31 Oct 2013. Available from: URL: http://www.bio-trends.com
Rights and permissions
About this article
Cite this article
Most oncologists using biosimilars within 12 months of launch. PharmacoEcon Outcomes News 691, 11 (2013). https://doi.org/10.1007/s40274-013-0880-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0880-x